Home/Pipeline/NaviFUS Neuromodulation for Stroke Rehabilitation

NaviFUS Neuromodulation for Stroke Rehabilitation

Stroke

Phase 1Active

Key Facts

Indication

Stroke

Phase

Phase 1

Status

Active

Company

A Taiwanese biotech leveraging non‑invasive focused ultrasound to breach the BBB for targeted CNS drug delivery.

Drug	Company	Phase	Status
NOX4 Inhibitor Platform	Glucox Biotech	Research	Active
LG3	Stream Biomedical	Pre-clinical	Active
Patient Transport Optimization	Zeto	Research	Active
NA-911	Biomed	Phase 2A	Active
DIASTROKE	Diagenics	Development/Commercial	Active
APOSEC	Aposcience	Pre-clinical	Active
NXL-001	NeuExcell Therapeutics	Phase 1	Active
Precision Neuromodulation for Stroke Recovery	Panaxium	Pre-clinical	Active
Autologous Wnt-activated ADSC Therapy	Regeneration Biomedical	Pre-clinical	Active
Banked Cord Blood Stem Cells	Cryo-Cell	Clinical Trials	Investigational